Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2016
  • 2015
  • 2014
  • 2011

Author

  • Keith Lindor
Article

ACG clinical guideline: Primary sclerosing cholangitis

Lindor, K., Kowdley, K. V. & Harrison, M. E., May 8 2015, In : American Journal of Gastroenterology. 110, 5, p. 646-659 14 p.

Research output: Contribution to journalArticle

191 Scopus citations
4 Scopus citations

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K. D., Apr 1 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

104 Scopus citations

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K. D., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

Antibiotics for the treatment of primary sclerosing cholangitis

Elfaki, D. A. H. & Lindor, K. D., May 1 2011, In : American Journal of Therapeutics. 18, 3, p. 261-265 5 p.

Research output: Contribution to journalArticle

17 Scopus citations

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

3 Scopus citations

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

358 Scopus citations

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Tabibian, J. H., Enders, F., Imam, M. H., Kolar, G., Lindor, K. & Talwalkar, J. A., 2014, In : Annals of Hepatology. 13, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Open Access
10 Scopus citations

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K. D., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., George, J., Barrera, F., Haflidadóttir, S., Björnsson, E. S., Armstrong, M. J., Hopkins, L. J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y. & 13 others, Lindor, K. D., Charlton, M., Haring, R., Lerch, M. M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L. L., Machado, M., Cortez-Pinto, H., Yasui, K. & Cassader, M., Jul 2014, In : PLoS Medicine. 11, 7, e1001680.

Research output: Contribution to journalArticle

226 Scopus citations

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

56 Scopus citations

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K. D., Bjornsson, E. & Koch, A., Jan 2011, In : Gastroenterology. 140, 1, p. 180-188 9 p.

Research output: Contribution to journalArticle

63 Scopus citations

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

2 Scopus citations

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Hepatology. 62, 5, p. 1620-1622 3 p.

Research output: Contribution to journalArticle

76 Scopus citations

Changing nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : American Journal of Gastroenterology. 110, 11, p. 1536-1538 3 p.

Research output: Contribution to journalArticle

22 Scopus citations

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Clinical Gastroenterology and Hepatology. 13, 11, p. 1867-1869 3 p.

Research output: Contribution to journalArticle

12 Scopus citations

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 2015, In : Gastroenterology. 149, 6, p. 1627-1629 3 p.

Research output: Contribution to journalArticle

50 Scopus citations

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E. & Lindor, K. D., Jan 1 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 52-56 5 p.

Research output: Contribution to journalArticle

46 Scopus citations

Development and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Lammers, W. J., Hirschfield, G. M., Corpechot, C., Nevens, F., Lindor, K., Janssen, H. L. A., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Parés, A., Burroughs, A. K., Mason, A. L., Kowdley, K. V., Kumagi, T., Harms, M. H., Trivedi, P. J., Poupon, R., Cheung, A. & 4 others, Lleo, A., Caballeria, L., Hansen, B. E. & Van Buuren, H. R., Dec 1 2015, In : Gastroenterology. 149, 7, p. 1804-1812.e4

Research output: Contribution to journalArticle

149 Scopus citations

Docetaxel Induced Sclerosing Cholangitis

Horsley-Silva, J. L., Dow, E. N., Menias, C. O., Smith, M. L., Carballido, E. M., Lindor, K. D. & Vargas, H. E., Dec 1 2015, In : Digestive Diseases and Sciences. 60, 12, p. 3814-3816 3 p.

Research output: Contribution to journalArticle

8 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., Trauner, M., Marschall, H. U., Adorini, L., Sciacca, C., Beecher-Jones, T., Castelloe, E., Böhm, O. & Shapiro, D., Apr 1 2015, In : Gastroenterology. 148, 4, p. 751-761.e8

Research output: Contribution to journalArticle

274 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Erratum: Primary biliary cirrhosis (Lancet (2015) 386 (1565-1575))

Carey, E. J., Ali, A. H. & Lindor, K., 2015, In : The Lancet. 386, 10003, p. 1536 1 p.

Research output: Contribution to journalArticle

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

11 Scopus citations

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K. D., May 1 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

38 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K. D., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

134 Scopus citations

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K. D., Nov 1 2011, In : American Journal of Therapeutics. 18, 6, p. e202-e208

Research output: Contribution to journalArticle

21 Scopus citations

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., May 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K. D., Nov 1 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

60 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

15 Scopus citations

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Global PBC Study Group, Dec 1 2014, In : Gastroenterology. 147, 6, p. 1338-1349.e5

Research output: Contribution to journalArticle

172 Scopus citations

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

4 Scopus citations

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Managing PBC: Expanding the Provider Comfort Zone

Chascsa, D. M. & Lindor, K., Jun 9 2018, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma

Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R. & Lindor, K. D., May 2011, In : Clinical Gastroenterology and Hepatology. 9, 5, p. 434-439.e1

Research output: Contribution to journalArticle

72 Scopus citations

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

13 Scopus citations

Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis

Imam, M. H., Eaton, J. E., Puckett, J. S., Loftus, E. V., Mathis, K. L., Gossard, A. A., Talwalkar, J. A. & Lindor, K., Oct 1 2014, In : Journal of Crohn's and Colitis. 8, 10, p. 1294-1299 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

New treatment strategies for primary sclerosing cholangitis

Lindor, K. D., Jun 1 2011, In : Digestive Diseases. 29, 1, p. 113-116 4 p.

Research output: Contribution to journalArticle

14 Scopus citations

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

Harms, M. H., De Veer, R. C., Lammers, W. J., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Trivedi, P. J., Hirschfield, G. M., Pares, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Hansen, B. E., Buuren, H. R. V. & 1 others, Van Der Meer, A. J., 2019, (Accepted/In press) In : Gut. 319057.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations